Founder, Seattle Biomedical Research Institute
Professor of Computer Science, UC San Diego
Head of global research and development at Life Technologies.
Partner, North Bridge Venture Partners
Lecturer, Boston University School of Management
Senior Partner, Bessemer Venture Partners
CEO and Fund Manager, Renaissance Venture Capital Fund
Co-Founder, Fate Therapeutics
|
|
| Entry | Author | Date | Location | |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Obtains $75,000,000 Series B Round | VentureDeal | 12/20/12 | San Francisco | |
| LS9 Pockets $30M for Renewable Fuels, in Deal Led by BlackRock | Luke Timmerman | 12/20/10 | San Francisco | |
| LS9 Receives $30,000,000 New Financing Round | VentureDeal | 12/20/10 | San Francisco | |
| Page 1 of 1 | ||||